Proteins & Antibodies Sponsors 2015

  • Aldevron

    Aldevron provides custom plasmid DNA manufacturing to support many gene and cell therapy applications. With our experience and scientific expertise, we have developed screening strategies to optimize yield and stability of even the most challenging vector plasmids. We also provide consistency at all levels, with a deliberate pathway from research to clinical requirements.  Visit with our team to learn about our additional services including, mRNA, protein production, gene synthesis and antibody development. Aldevron's mission is to advance science, and we have solutions that are designed for you.

  • Bachem

  • DNA 2.0

    DNA2.0 is the leading bioengineering solutions provider. Founded in 2003, DNA2.0 provides an integrated pipeline of solutions for the research community, including gene design, optimization, synthesis and cloning, as well as platforms for protein and strain engineering. It is the fastest provider of synthetic genes—based in the US with a global customer base encompassing academia, government and the pharmaceutical, chemical, agricultural and biotechnology industries. DNA2.0 is by far the most published synthetic gene vendor, providing expert support to and collaboration with scientists. DNA2.0 explores novel applications for synthetic genes and is exploiting the synergy between highly efficient gene design and synthesis processes and new protein optimization technologies. DNA2.0’s tools and solutions are fueling the transformation of biology from a discovery science to an engineering discipline. The company is privately held and is headquartered in Menlo Park, California.

  • Eurogentec

  • Schrodinger

  • Sigma-Aldrich

  • Xbrane Bioscience

    Xbrane Bioscience aims to take protein production in E. coli to the next level. By innovative titratable technology and world leading Know-How we enable our customer to produce their proteins in a controllable system, with higher yields and better quality. Xbrane Bioscience was founded in early 2008 in order to commercialize innovations based on research made by Dr. Jan-Willem de Gier and Dr. Samuel Wagner at the Center for Biomembrane Research at the Arrhenius Laboratories at Stockholm University. Today the company still have extensive collaboration with several academic groups. The company is situated in close proximity to Stockholm University providing access to renowned research expertise and infrastructure.